[具体药物或物质名称]治疗炎症性肠病的潜在治疗作用。 （原文中“for”前面缺少具体内容，这里补充为“[具体药物或物质名称]”，以使译文完整通顺）
The potential therapeutic role of for treatment of inflammatory bowel disease.
作者信息
Wang Huiyu, Zhou Chunli, Huang Junxiang, Kuai Xiaoyi, Shao Xinyu
机构信息
Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University Suzhou, Jiangsu, China.
出版信息
Am J Transl Res. 2020 May 15;12(5):1569-1583. eCollection 2020.
Abstract
Inflammatory bowel disease (IBD) is a chronic intestinal disease of unknown etiology. However, recent studies have established a pathological role of disordered intestinal microbiota and immune dysregulation. Clinical studies have suggested that the reconstruction of the normal intestinal flora in patients with IBD can reverse the dysbiosis caused by genetic, environmental, dietary, or antibiotic factors to ameliorate the symptoms of IBD. is widely present in the intestines of healthy individuals and regulates the intestinal immune system, reducing inflammation through multiple mechanisms. This review summarizes the current knowledge of the role of in maintaining intestinal homeostasis and considers its possible value as a new therapeutic agent for patients with IBD.
摘要
炎症性肠病（IBD）是一种病因不明的慢性肠道疾病。然而，最近的研究已经证实肠道微生物群紊乱和免疫失调在其病理过程中发挥作用。临床研究表明，重建IBD患者的正常肠道菌群可以逆转由遗传、环境、饮食或抗生素因素引起的生态失调，从而改善IBD的症状。 广泛存在于健康个体的肠道中，并调节肠道免疫系统，通过多种机制减轻炎症。本综述总结了目前关于 在维持肠道稳态中作用的认识，并探讨了其作为IBD患者新型治疗药物的潜在价值。
相似文献
1
The potential therapeutic role of for treatment of inflammatory bowel disease.[具体药物或物质名称]治疗炎症性肠病的潜在治疗作用。 （原文中“for”前面缺少具体内容，这里补充为“[具体药物或物质名称]”，以使译文完整通顺）
Am J Transl Res. 2020 May 15;12(5):1569-1583. eCollection 2020.
2
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
3
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.炎症性肠病和结直肠癌中的微生物群变化：结肠细胞反应的改变
World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121.
4
Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.肠道微生物群发病机制及粪便微生物群移植治疗炎症性肠病
World J Gastroenterol. 2014 Oct 28;20(40):14805-20. doi: 10.3748/wjg.v20.i40.14805.
5
Fecal Microbiota Transplantation in Inflammatory Bowel Disease.炎症性肠病中的粪便微生物群移植
Dig Dis. 2017;35(1-2):123-126. doi: 10.1159/000449092. Epub 2017 Feb 1.
6
The role of potential probiotic strains in various intestinal diseases: New roles for an old player.潜在益生菌菌株在各种肠道疾病中的作用：老角色的新作用。
Front Microbiol. 2023 Feb 2;14:1095555. doi: 10.3389/fmicb.2023.1095555. eCollection 2023.
7
The gut microbiota and inflammatory bowel disease.肠道微生物群与炎症性肠病
Semin Immunopathol. 2015 Jan;37(1):47-55. doi: 10.1007/s00281-014-0454-4. Epub 2014 Nov 25.
8
[Inflammatory bowel diseases and enteric microbiota].[炎症性肠病与肠道微生物群]
Korean J Gastroenterol. 2010 Jan;55(1):4-18. doi: 10.4166/kjg.2010.55.1.4.
9
Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.目前对微生物群和饮食疗法治疗炎症性肠病的理解。
J Microbiol. 2018 Mar;56(3):189-198. doi: 10.1007/s12275-018-8049-8. Epub 2018 Feb 28.
10
Purinergic signaling during intestinal inflammation.嘌呤能信号在肠道炎症中的作用。
J Mol Med (Berl). 2017 Sep;95(9):915-925. doi: 10.1007/s00109-017-1545-1. Epub 2017 May 26.
引用本文的文献
1
The efficacy of lactobacillus reuteri in conjunction with racecadotril in managing pediatric rotavirus enteritis and its impact on intestinal mucosa and immune function.罗伊氏乳杆菌联合消旋卡多曲治疗小儿轮状病毒性肠炎的疗效及其对肠黏膜和免疫功能的影响
Afr Health Sci. 2025 Jun;25(2):38-45. doi: 10.4314/ahs.v25i2.6.
2
Microbiota composition-based donor selection affects FMT efficacy in a murine colitis model.基于微生物群组成的供体选择会影响小鼠结肠炎模型中粪菌移植的疗效。
Front Immunol. 2025 Aug 1;16:1635244. doi: 10.3389/fimmu.2025.1635244. eCollection 2025.
3
Limosilactobacillus reuteri SXDT-32-derived shikimic acid protects against colonic inflammation in piglets by inhibiting the PI3K-Akt pathway.罗伊氏乳杆菌SXDT-32产生的莽草酸通过抑制PI3K-Akt途径预防仔猪结肠炎症。
J Anim Sci Biotechnol. 2025 Jun 13;16(1):84. doi: 10.1186/s40104-025-01221-w.
4
Impact of chronic consumption of probiotics, oats, and apples on expression of genes related to bile acids, lipid, gut peptides, and inflammation in peripheral monocular cells - findings from the CABALA study.长期食用益生菌、燕麦和苹果对周围单核细胞中与胆汁酸、脂质、肠道肽及炎症相关基因表达的影响——CABALA研究结果
Eur J Nutr. 2025 May 10;64(4):176. doi: 10.1007/s00394-025-03694-x.
5
Probiogenomic analysis of SD7, a probiotic candidate with remarkable aggregation abilities.对具有显著聚集能力的益生菌候选菌株SD7进行益生菌基因组分析。
Heliyon. 2025 Feb 3;11(3):e42451. doi: 10.1016/j.heliyon.2025.e42451. eCollection 2025 Feb 15.
6
Real-world of Limosilactobacillus reuteri in mitigation of acute experimental colitis.罗伊氏乳杆菌在减轻急性实验性结肠炎中的实际应用
J Nanobiotechnology. 2025 Jan 31;23(1):65. doi: 10.1186/s12951-025-03158-8.
7
Alteration of the Gut-Lung Axis After Severe COVID-19 Infection and Modulation Through Probiotics: A Randomized, Controlled Pilot Study.严重 COVID-19 感染后肠道-肺部轴的改变及益生菌的调节：一项随机对照的初步研究。
Nutrients. 2024 Nov 8;16(22):3840. doi: 10.3390/nu16223840.
8
Development of a novel complex inflammatory bowel disease mouse model: Reproducing human inflammatory bowel disease etiologies in mice.一种新型复杂炎症性肠病小鼠模型的构建：在小鼠中重现人类炎症性肠病的病因。
PLoS One. 2024 Nov 21;19(11):e0311310. doi: 10.1371/journal.pone.0311310. eCollection 2024.
9
Protective effect of a newly probiotic Lactobacillus reuteri LY2-2 on DSS-induced colitis.新型益生菌鼠李糖乳杆菌 LY2-2 对 DSS 诱导结肠炎的保护作用。
Eur J Nutr. 2024 Nov 15;64(1):5. doi: 10.1007/s00394-024-03535-3.
10
Evaluating the Therapeutic Efficacy of Strains in the Management of Ulcerative Colitis: An Overview of Recent Advances.评估菌株在溃疡性结肠炎治疗中的疗效：近期进展概述
Curr Pharm Des. 2025;31(6):413-421. doi: 10.2174/0113816128322653240925115114.
本文引用的文献
1
Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease.免疫机制是粪菌移植治疗炎症性肠病的基础。
Clin Exp Immunol. 2020 Jan;199(1):24-38. doi: 10.1111/cei.13397. Epub 2019 Nov 27.
2
Beneficial effects of Lactobacillus reuteri 6475 on bone density in male mice is dependent on lymphocytes.罗伊氏乳杆菌 6475 对雄性小鼠骨密度的有益作用依赖于淋巴细胞。
Sci Rep. 2019 Oct 11;9(1):14708. doi: 10.1038/s41598-019-51293-8.
3
Additional administration enhances the severity of dextran sulfate solution induced colitis mouse model through leaky gut-enhanced systemic inflammation and gut-dysbiosis but attenuated by L34. 额外的给药通过渗漏肠道增强的全身炎症和肠道菌群失调加重葡聚糖硫酸钠溶液诱导的结肠炎小鼠模型的严重程度，但被 L34 减轻。
Gut Microbes. 2020 May 3;11(3):465-480. doi: 10.1080/19490976.2019.1662712. Epub 2019 Sep 18.
4
DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites.DSM 17938 喂养健康的新生小鼠可调节免疫反应，同时调节肠道微生物群并增加有益代谢物。
Am J Physiol Gastrointest Liver Physiol. 2019 Dec 1;317(6):G824-G838. doi: 10.1152/ajpgi.00107.2019. Epub 2019 Sep 4.
5
Bone alterations in inflammatory bowel diseases.炎症性肠病中的骨骼改变
World J Clin Cases. 2019 Aug 6;7(15):1908-1925. doi: 10.12998/wjcc.v7.i15.1908.
6
The effect of prebiotic fortified infant formulas on microbiota composition and dynamics in early life.含益生元的婴儿配方对生命早期微生物群落组成和动态的影响。
Sci Rep. 2019 Feb 21;9(1):2434. doi: 10.1038/s41598-018-38268-x.
7
What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases.健康的肠道微生物群组成是怎样的？一个随年龄、环境、饮食和疾病变化的生态系统。
Microorganisms. 2019 Jan 10;7(1):14. doi: 10.3390/microorganisms7010014.
8
Gut Symbionts Lactobacillus reuteri R2lc and 2010 Encode a Polyketide Synthase Cluster That Activates the Mammalian Aryl Hydrocarbon Receptor.肠道共生菌乳杆菌 R2lc 和 2010 编码了一个聚酮合酶簇，该簇可以激活哺乳动物芳烃受体。
Appl Environ Microbiol. 2019 May 2;85(10). doi: 10.1128/AEM.01661-18. Print 2019 May 15.
9
Lactobacillus reuteri F-9-35 Prevents DSS-Induced Colitis by Inhibiting Proinflammatory Gene Expression and Restoring the Gut Microbiota in Mice.罗伊氏乳杆菌 F-9-35 通过抑制促炎基因表达和恢复肠道微生物群预防 DSS 诱导的结肠炎。
J Food Sci. 2018 Oct;83(10):2645-2652. doi: 10.1111/1750-3841.14326. Epub 2018 Sep 14.
10
Effects of dietary tryptophan supplementation in the acetic acid-induced colitis mouse model.膳食色氨酸补充对乙酸诱导结肠炎模型小鼠的影响。
Food Funct. 2018 Aug 15;9(8):4143-4152. doi: 10.1039/c8fo01025k.
Zotero 插件